Imaging agents
Imaging agents
| Affibody® Research Reagent | Catalog number | Size | Price |
|---|---|---|---|
Anti-EGFR imaging agent |
10.2023.01.0005 |
500 µg |
€ 715 |
Anti-EGFR imaging agent |
10.2023.01.0001 |
100 µg |
€ 170 |
Anti-HER2, imaging agent |
10.1861.01.0001 |
100 µg |
€ 315 |
Anti-HER2, imaging agent |
10.1861.01.0005 |
500 µg |
€ 1 455 |
Imaging agent negative control |
10.2046.01.0005 |
500 µg |
€ 465 |
Affibodys latest Press releases
2023-01-05
Positive Top-line Clinical Data for Izokibep in Hidradenitis Suppurativa
Affibody in short
Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
Upcoming reports Financial calendar
- Interim Report January to March 2020 (May 15, 2020)
- Interim Report January to June 2020 (August 21, 2020)
- Interim Report January to September 2020 (November 13, 2020)
- Year End Report 2020 (February 2021)